Psychosocial Factors Are Associated With Blood Pressure Progression Among African Americans in the Jackson Heart Study

Size: px
Start display at page:

Download "Psychosocial Factors Are Associated With Blood Pressure Progression Among African Americans in the Jackson Heart Study"

Transcription

1 Original Article Psychosocial Factors Are Associated With Blood Pressure Progression Among African Americans in the Jackson Heart Study Cassandra D. Ford, 1 Mario Sims, 2 John C. Higginbotham, 3 Martha R. Crowther, 4 Sharon B. Wyatt, 2,5, Solomon K. Musani, 2 Thomas J. Payne, 6 Ervin R. Fox, 2 and Jason M. Parton 7 BACKGROUND Research that examines the associations of psychosocial factors with incident hypertension among African Americans (AA) is limited. Using Jackson Heart Study (JHS) data, we examined associations of negative affect and stress with incident hypertension and blood pressure (BP) progression among AA. METHODS Our sample consisted of 1,656 normotensive participants at baseline ( ) (mean age 47 ± 12; 61% women). We investigated associations of negative affect (cynical distrust, anger-in, anger-out, and depressive symptoms) and stress (perceived stress, weekly stress inventory (WSI)-event, WSI-impact, and major life events) with BP progression (an increase by one BP stage as defined by JNC VII) and incident hypertension by examination 2 ( ). Poisson regression analysis was utilized to examine the prevalence ratios (PRs; 95% confidence interval (CI)) of BP tracking and incident hypertension with psychosocial factors, adjusting for baseline age, sex, socioeconomic status (SES), and hypertension risk factors. RESULTS Fifty-six percentage of the sample (922 cases) had BP progression from 2005 to After adjustment for age, sex, and SES, a high anger-out score was associated with a 20% increased risk of BP progression compared to a low anger-out score (PR 1.20; 95% CI ). High depressive symptoms score was associated with BP progression in the age, sex, and SES-adjusted model (PR 1.14; 95% CI ). High WSI-event scores were associated with BP progression in the fully adjusted model (PR 1.21; 95% CI ). We did not observe significant associations with any of the psychosocial measures and incident hypertension. CONCLUSIONS Psychosocial factors were associated with BP progression, with the strongest evidence for number of stressful events that occurred. Keywords: African Americans; blood pressure; health disparities; hypertension; Jackson Heart Study; psychosocial. doi: /ajh/hpw013 Hypertension is a risk factor for cardiovascular disease (CVD), affecting 77.9 million adults in the United States. 1,2 While the prevalence among men and women is nearly equivalent (33.6% and 32.3%, respectively), 3 previous studies report a higher prevalence of among African Americans (AA) than other groups. 4,5 Although rates of control have improved among AA, disparities persist 6,7 and continue to increase. 3 Studies also report a higher incidence of hypertension in AA than Whites While hypertension is attributed to known risk factors (i.e., age, diet, family history), 5,11,12 psychosocial factors may also contribute to hypertension risk and related CVD risk factors Yan et al. 17 found that greater hostility and time urgency impatience were associated with a higher risk of hypertension among AA and White young adults. Cohen and colleagues 18 discussed the impact of mental health factors (i.e., depression, anxiety, and stress) and the extent to which they are associated with CVD and related risk factors. Research has reported that greater levels of depressive symptoms were associated with incident hypertension, 19,20 and that increased negative affect was associated with hypertension risk among AA and Whites. 21 There is limited research on psychosocial factors and blood pressure (BP) risk in large AA samples. Previous Correspondence: Cassandra D. Ford (ford039@ua.edu). Initially submitted September 14, 2015; date of first revision October 4, 2015; accepted for publication January 22, 2016; online publication March 10, Capstone College of Nursing, The University of Alabama, Tuscaloosa, Alabama, USA; 2 Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi, USA; 3 College of Community Health Sciences, The University of Alabama, Tuscaloosa, Alabama, USA; 4 Department of Psychology, The University of Alabama, Tuscaloosa, Alabama, USA; 5 School of Nursing, University of Mississippi Medical Center, Jackson, Mississippi, USA; 6 Department of Otolaryngology and Communicative Sciences, University of Mississippi Medical Center, Jackson, Mississippi, USA; 7 Culverhouse College of Commerce and Business Administration, The University of Alabama, Tuscaloosa, Alabama, USA. Deceased. American Journal of Hypertension, Ltd All rights reserved. For Permissions, please journals.permissions@oup.com American Journal of Hypertension 29(8) August

2 Ford et al. studies have examined few psychosocial measures, which limits the ability to fully capture the extent to which psychological ill-being predicts BP outcomes. Since research has primarily examined psychosocial factors and incident hypertension as an outcome, it is important to examine the extent to which psychosocial factors are associated outcomes other than incident hypertension (such as BP progression and changes in systolic and diastolic BP). Using Jackson Heart Study (JHS) data, we hypothesized that higher levels of negative affect (cynical distrust, anger-in, anger-out, and depressive symptoms) and stress (global stress, weekly stress, and major life events (MLEs)) are associated with BP progression, incident hypertension, and changes in systolic and diastolic BP among AA between and METHODS Study population The JHS, an observational study of the etiology of CVD among AA, includes 5,301 men and women (21 95 years old) at the baseline examination ( ) living in the tri-county area of Jackson, MS. Examination 2 ( ) included 4,203 participants. Each examination included a physical examination, blood/urine analyses, and interview questions including psychosocial measures. Further details about data collection are described elsewhere. 22,23 The study was approved by the Institutional Review Boards of the 3 participating universities and participants provided informed consent. BP measures Standardized protocols were used for examinations 1 and 2. Systolic BP (SBP) and diastolic BP (DBP) were measured twice in the right arm of participants using the random-zero BP sphygmomanometer (Hawksley and Sons Limited, Sussex, England). The first BP measurement was taken after the participant rested for 5 minutes in a seated position; the second BP was taken after waiting an additional minute. The average of the 2 measurements comprised the BP measure for the examination. For the primary analysis, we examined BP progression (increase) by at least one category according to the Joint National Committee (JNC VII) on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. We also performed the analysis using JNC VI criteria; however, since results varied little, we present only results for JNC VII criteria. We also examined incident hypertension and longitudinal changes in SBP and DBP. The categories utilized for BP progression included normal BP (<120/80 mm Hg), prehypertension ( /80 89 mm Hg), stage 1 ( /90 99 mm Hg) and stage 2 ( 160/ 100) hypertension. Categories for BP progression were classified according to JNC VII guidelines which showed the level of progression and how much SBP and DBP progressed. Incident hypertension was defined as new cases of hypertension from examination 1 to 2 and was derived from a BP of 140/90 mm Hg or higher, reported taking antihypertensive medications, pill bottle review, or being told by a provider that one has hypertension. Longitudinal changes in SBP and DBP were measured as continuous changes between examination 1 and 2. Psychosocial factors Baseline psychosocial measures included cynical distrust, anger-in and -out, depressive symptoms, global stress, weekly stress inventory (WSI)-event, WSI-impact, and MLE. Cynical distrust was measured as a component of the Cook Medley Hostility Scale, 24 where participants were asked to answer true or false on such questions as.it is safer to trust nobody. We calculated a cynical distrust score where the total average of all true responses was divided by 13 (range 0 13). Cronbach s alpha was Anger was measured using the Spielberger trait anger scale, a 16-item scale that assesses anger-in (8 items) and anger-out (8 items). 25,26 Participants were asked to rate how often they reacted to: I keep things in ; I express my anger. Each item is rated from never (0) to almost always (5). The average of both was derived and ranged from 0 to 23 (anger-in) and 0 to 22 (anger-out). In general, internal consistency coefficients for the scale were , and the range for test retest reliability coefficients was For this specific study, internal consistency was good for the scale: total anger (α = 0.81), anger-in (α = 0.77), and anger-out (α = 0.77). Depressive symptoms were measured using the 20-item Centers for Epidemiologic Studies Depression Scale (CES- D) that measures frequency of depressive symptoms. 28 Participants were asked about their mood over the past week, responding to each item (e.g., I was bothered by things that usually don t bother me ). Item ratings ranged from 0 ( rarely/none of the time ) to 3 ( most/all of the time ). This scale ranged from 0 to 60 with higher scores reflecting greater levels of depressive symptoms. Cronbach s alpha was Global perceived stress was created for the JHS 29 and adapted from standardized stress scales. 30,31 Participants rated the extent of chronic stress from 8 domains (e.g., employment, relationships) over a 12-month period. Choices ranged from not stressful (=1) to very stressful (=3); summing items yields a total score ranging from 0 to 24. Cronbach s alpha was The WSI, developed by Jones and Brantley, 32,33 is an 87-item questionnaire that measured occurrence of minor irritants (e.g., work tasks, financial challenge) during the past week and the extent of stressfulness based on a 7-point Likert-type scale (1 = not stressful; 7 = extremely stressful). We measured WSI-event, the number of stressful events endorsed (range 0 87), and WSI-impact, the sum of the subjective ratings assigned to endorsed events (range 0 493). 33 Cronbach s alpha was MLEs were assessed using an 11-item life events inventory. 34 The MLE, administered at annual follow-up, measured whether participants experienced events in the last 12 months by answering yes or no to select items (experiencing illness, being a victim of assault). The total score was calculated by summing the yes (=1) responses where the range was Since the MLE is an index rather than a true scale, Cronbach s alpha was not calculated. We constructed cumulative scores for negative affect and stress measures. 16 Cumulative negative affect was constructed by assigning a separate score of 1 (referent) to 3 to tertiles of the cynical distrust, anger-in and -out, and depression measures separately and summing across the American Journal of Hypertension 29(8) August 2016

3 Psychosocial Factors and BP Progression measures (range 4 12). Cumulative stress was constructed by assigning a separate score of 1 (referent) to 3 to tertiles of the global stress, WSI-event, WSI-impact, and MLE measures separately and summing across the 4 measures (range 4 12). Covariates Covariates included baseline age (continuous), sex (men/women (referent)), education, cigarette smoking, physical activity, diet, body mass index, type 2 diabetes, total cholesterol, SBP, and DBP. Education was classified as less than high school (referent), high school graduate to some college, or college graduate and above. Cigarette smoking status was classified as current, former, and never (referent). Physical activity was measured as a continuous sum of the 4 index scores (Active Living, Work/ Occupational, Home Life, and Sport) from the JHS physical activity instrument. 35 Diet was assessed using a validated 158-item questionnaire. 36 Measures related to the Dietary Approaches to Stop Hypertension trial 37 (percent calories from fat, sodium (mg/1,000 kcal), potassium (mg/1,000 kcal), calcium (mg/kcal), and total fiber (g/1,000 kcal)) were examined. Body mass index was calculated as weight in kilograms divided by height in meters squared. Type 2 diabetes was defined according to American Diabetes Association (ADA) 2004 criteria as fasting glucose 126 mg/dl, or confirmed medication usage from the medication inventory, or self-reported use of antidiabetic medications within the past 2 weeks of the examination, or self-reported diabetes diagnosis. Total cholesterol was assayed by the cholesterol oxidase method supplied by Boehringer Mannheim Diagnostics on a Roche COBAS Fara analyzer (Indianapolis, IN). Baseline hypertension was defined as a SBP 140 mm Hg or DBP 90 mm Hg and/or antihypertensive medication. Statistical analysis Descriptive statistics were presented, in that we characterized the sample by BP progression status. Differences were tested using chi-square or analysis of variance tests for categorical and continuous variables, respectively. Next, associations of psychosocial measures with each BP end point were estimated. Multivariable Poisson regression analysis estimated the associations of psychosocial factors with BP progression with robust SEs, where prevalence (risk) ratios (PRs; 95% confidence interval (CI)) estimated the prevalence of BP progression. Psychosocial factors were measured in tertiles in order to assess threshold effects and as continuous variables in SD units. P for trend, estimated for tertiles of each psychosocial measure, represented the linear trend across categories. A sensitivity test was conducted to examine associations of psychosocial factors with BP progression from normotensive status only to stage 1 and 2 hypertension, and associations with progression from prehypertensive status only to stage 1 and 2 hypertension. Poisson regression was used to estimate these models, and fully adjusted predicted values for the 2 outcomes were graphically displayed for select psychosocial variables. The associations of psychosocial measures (SD units) with incident hypertension were estimated using multivariable Poisson regression. Poisson regression was used for this and the BP-progression analyses because prevalence of BP progression was 56%, and incident hypertension was 37%. 38 The associations of psychosocial factors with changes in SBP and DBP between examination 1 and 2 were examined using multivariable linear regression to estimate mean differences (SEs) in changes in SBP and DBP. For participants taking antihypertensive medications, Bs were imputed by adding 10 mm Hg to the SBP and 5 mm Hg to the DBP in each of the analyses. We also performed imputations by adding 15 mm Hg to the SBP and 10 mm Hg to the DBP. 39,40 Since results were similar, we reported those for the first imputation. For each BP end point, models were estimated sequentially. Model 1 adjusted for age, sex, and psychosocial factors; model 2 adjusted for model 1 plus education; model 3 adjusted for model 2 plus smoking, sodium intake, calories from fat, total fiber, physical activity, body mass index, type 2 diabetes, and total cholesterol. In the BP progression and incident hypertension analyses, we added model 4 that adjusted for model 3 plus baseline SBP and DBP. In order to avoid multicolinearity, each psychosocial measure was analyzed in separate models. A test for interactions between sex and psychosocial measures was calculated in fully adjusted models to examine potential effect modification by sex. All reported s correspond to 2-tailed tests and were significant at the 0.05 level. Due to performing multiple test scenarios that puts us at an increased risk for type I error, we have implemented a Bonferroni method of correction, for all comparisons and presented the adjusted P values for multiple testing in Tables 2 4. The following correction for multiple testing was used for the 3 negative affect measures: 0.05/3 = or The following correction was used for the 3 stress measures: 0.05/3 = or Both unadjusted and adjusted s will be considered in our analysis. All analyses were performed using STATA 13.0 (STATA Corp, College Station, TX). RESULTS Sample characteristics Fifty-three (53) participants with missing data on hypertension and 3,301 hypertensives at baseline were excluded. Two hundred ninety-one (291) participants had missing data on education, smoking, physical activity, and diet variables. This left 1,656 participants free of hypertension at baseline in the final sample (mean age 47 ± 12; 61% women). The median follow-up period was 5.0 ± 0.8 years. Fifty-six percentage (56%) of the sample progressed at least one BP stage from to (Table 1). Incident hypertension occurred among 37.4% of normotensives at baseline, and mean increase in SBP and DBP were 6.5 and 3.7 mm Hg, respectively. BP progression Table 2 presents associations of each psychosocial factor with BP progression in sex-pooled models. There were American Journal of Hypertension 29(8) August

4 Ford et al. Table 1. Characteristics of study population by evidence of blood pressure progression (between baseline and examination 2), Jackson Heart Study, and BP progression JNC VII criteria Without BP progression; 44% (n = 734) With BP progression; 56% (n = 922) Demographic and SES factors Mean age (SD) (12.28) (12.66) 0.37 Education (%) <High school High school 4 College College Psychosocial factors (mean, SD) Cynical distrust 6.63 (3.18) 6.84 (3.11) 0.29 Anger-in 5.70 (3.51) 5.84 (3.73) 0.52 Anger-out 4.44 (3.05) 4.83 (3.06) 0.04 Depressive symptoms 9.73 (7.47) (8.44) 0.00 Perceived stress 5.70 (4.37) 5.66 (4.54) 0.85 WSI-event (23.76) (22.87) 0.09 WSI-impact (83.42) (85.24) 0.14 Major life events 3.33 (1.37) 3.46 (1.36) 0.07 Cumulative negative affect 7.53 (2.17) 7.81 (2.16) 0.05 Cumulative stress 7.64 (2.15) 8.05 (2.19) 0.00 Risk factors Cigarette smoking (%) Never smoked Former smokers Current smoker Physical activity score (mean, SD) 9.17 (2.44) 8.91 (2.48) 0.04 Calories from fat (%) Sodium in diet (mg) (mean, SD) 4, (2,623.95) 4, (2,693.73) 0.37 Potassium (mg) (mean, SD) 2, (1,589.30) 2, (1,544.93) 0.46 Calcium (mg) (mean, SD) (579.80) (532.46) 0.15 Total dietary fiber (g) (mean, SD) (9.76) (8.67) 0.75 BMI (m, SD) (6.60) (7.33) 0.10 Diabetes (%) Total cholesterol (mg/dl) (mean, SD) SBP (mean, SD) (18.48) (17.40) 0.75 DBP (mean, SD) (11.18) (9.76) 0.46 JNC VII BP category (%) Normal Prehypertensive Sample sizes for each psychosocial factor: cynical distrust score, n = 1,037; anger-in score, n = 1,057; anger-out score, n = 1,074; depression score, n = 1,044; perceived stress score, n = 1,647; WSI-event score, n = 1,182; WSI-impact score, n = 1,015; major life events, n = 1,510; cumulative negative affect, n = 921; cumulative stress score, n = 927. based on chi-square and ANOVA tests. Normotensive status is defined as SBP < 120 mm Hg; DBP < 80 mm Hg. Prehypertensive is defined as SBP mm Hg; DBP mm Hg. Cumulative negative affect is the combination of standardized cynical distrust, anger-in, anger-out, and depressive symptoms. Cumulative stress is the combination of standardized global perceived stress, WSI-event, WSI-impact, and major life events stress. Abbreviations: ANOVA, analysis of variance; BMI, body mass index; BP, blood pressure; DBP, diastolic blood pressure; JNC, Joint National Committee; SBP, systolic blood pressure; SES, socioeconomic status; WSI, weekly stress inventory. 916 American Journal of Hypertension 29(8) August 2016

5 Psychosocial Factors and BP Progression Table 2. PRs of blood pressure progression (JNC VII criteria) with psychosocial factors among African Americans, Jackson Heart Study, and a Cases/people at risk Model 1 Model 2 Model 3 Cynical distrust Low (N = 351; 4.0 ± 1.6) 180/351 Referent Referent Referent Medium (N = 464; 7.0 ± 1.1) 255/ ( ) ( ) ( ) 0.36 High (N = 222; 11.0 ± 0.9) 125/ ( ) ( ) ( ) 0.92 P for trend Cynical distrust (SD units) 1.03 ( ) ( ) ( ) 0.52 Anger-in Low (N = 432; 3.0 ± 1.3) 232/432 Referent Referent Referent Medium (N = 248; 5.0 ± 0.5) 134/ ( ) ( ) ( ) 0.62 High (N = 377; 9.0 ± 2.8) 208/ ( ) ( ) ( ) 0.54 P for trend Anger-in (SD units) 1.02 ( ) ( ) ( ) 0.64 Anger-out Low (N = 435; 2.0 ± 1.0) 216/435 Referent Referent Referent Medium (N = 270; 5.0 ± 0.5) 151/ ( ) ( ) ( ) 0.23 High (N = 369; 8.0 ± 2.2) 218/ ( ) 0.01 b 1.20 ( ) 0.01 b 1.13 ( ) 0.09 P for trend Anger-out (SD units) 1.06 ( ) 0.03 b 1.06 ( ) 0.03 b 1.02 ( ) 0.51 Depressive symptoms Low (N = 375; 3.0 ± 2.0) 191/375 Referent Referent Referent Medium (N = 336; 9.0 ± 1.6) 173/ ( ) ( ) ( ) 0.91 High (N = 333; 17.0 ± 7.1) 201/ ( ) 0.01 b 1.14 ( ) 0.05 b 1.12 ( ) 0.16 P for trend Depression (SD units) 1.08 ( ) b 1.06 ( ) 0.02 b 1.05 ( ) 0.13 Perceived stress Low (N = 469; 1.0 ± 0.8) 271/469 Referent Referent Referent Medium (N = 550; 4.0 ± 1.1) 301/ ( ) ( ) ( ) 0.73 High (N = 628; 10.0 ± 3.1) 347/ ( ) ( ) ( ) 0.40 P for trend Perceived stress (SD units) 1.00 ( ) ( ) ( ) 0.51 WSI-event Low (N = 317; 12.0 ± 6.0) 156/317 Referent Referent Referent Medium (N = 413; 28.0 ± 5.1) 234/ ( ) 0.04 b 1.17 ( ) 0.03 b 1.20 ( ) 0.02 b High (N = 452; 58.0 ± 15.8) 258/ ( ) 0.03 b 1.17 ( ) 0.03 b 1.24 ( ) 0.01 b P for trend WSI-event (SD units) 1.05 ( ) ( ) ( ) 0.07 WSI-impact Low (N = 299; 20.0 ± 10.6) 146/299 Referent Referent Referent Medium (N = 335; 56.0 ± 14.5) 192/ ( ) 0.03 b 1.19 ( ) 0.03 b 1.18 ( ) 0.05 b High (N = 381; ± 80.3) 213/ ( ) 0.05 b 1.15 ( ) ( ) 0.14 P for trend WSI-impact (SD units) 1.04 ( ) ( ) ( ) 0.14 American Journal of Hypertension 29(8) August

6 Ford et al. Table 2. Continued Cases/people at risk Model 1 Model 2 Model 3 Major life events Low (N = 879; 2.0 ± 0.5) 456/879 Referent Referent Referent Medium (N = 360; 4.0 ± 0.0) 198/ ( ) ( ) ( ) 0.43 High (N = 271; 5.0 ± 1.0) 160/ ( ) 0.04 b 1.13 ( ) 0.05 b 1.07 ( ) 0.31 P for trend Major life events (SD units) 1.04 ( ) ( ) ( ) 0.41 Cumulative negative affect Low (N = 316; 5.0 ± 0.7) 157/316 Referent Referent Referent Medium (N = 390; 8.0 ± 0.8) 214/ ( ) ( ) ( ) 0.34 High (N = 215; 10.0 ± 0.7) 120/ ( ) ( ) ( ) 0.85 P for trend Cumulative negative affect 1.06 ( ) 0.05 b 1.05 ( ) ( ) 0.50 (SD units) Cumulative stress Low (N = 268; 5.0 ± 0.8) 127/268 Referent Referent Referent Medium (N = 423; 8.0 ± 0.8) 221/ ( ) ( ) ( ) 059 High (N = 236; 10.0 ± 0.8) 142/ ( ) b 1.30 ( ) b 1.24 ( ) 0.02 b P for trend Cumulative stress (SD units) 1.11 ( ) b 1.11 ( ) b 1.10 ( ) 0.01 b Abbreviations: BMI, body mass index; BP, blood pressure; CI, confidence interval; JNC, Joint National Committee; PR, prevalence ratio; SES, socioeconomic status; WSI, weekly stress inventory. a Low, medium, and high represent the first, second, and third tertile of each psychosocial factor at baseline. Sample size, N, and median ± SD are noted in parenthesis for tertile of psychosocial factor; cases represent participants who had progression of BP by at least one category of BP; PR estimates for blood progression represent the prevalence (or risk) of progressing upward by at least one category of BP based on JNC VII criteria. Standardized regression coefficients are presented for blood progression per 1-SD increment of each psychosocial factor. Model 1 is adjusted for age, sex, and psychosocial factor; model 2 is adjusted for model 1 + education; model 3 is adjusted for model 2 + current smoking, sodium intake, calories from fat, total fiber, physical activity, BMI, type 2 diabetes, and total cholesterol. P for trend represents the linear trend across categories for each psychosocial factor. Regression models for each psychosocial measure were restricted to the following analytic samples: cynical distrust (1,037), anger-in (1,057), anger-out (1,074), depressive symptoms (1,044), global perceived stress (1,647), WSI-event (1,182), WSI-impact (1,015), major life events (1,510), cumulative negative affect (921), and cumulative stress (927). Cumulative negative affect is the combination of standardized cynical distrust, anger-in, anger-out, and depressive symptoms. Cumulative stress is the combination of standardized global perceived stress, WSI-event, WS-impact, and major life events stress. b Bonferroni-adjusted for multiple testing: 0.02 (negative affect measures) and 0.02 (stress measures). moderate correlations between cynical distrust and angerin (Pearson s coefficient: 0.24; P < 0.001), depressive symptoms and cynical distrust (0.32; P < 0.001), and depressive symptoms and anger-in (0.45; P < 0.001). There were also weak-to-moderate correlations between the stress measures: MLE and WSI-event (0.08; P < 0.01), global stress and WSIimpact (0.39; P < 0.001). A high anger-out score was associated with a 20% increased risk of BP progression compared to a low anger-out score (PR 1.20; 95% CI ) (model 1). The association remained significant after adjustment for socioeconomic status (SES). There was a graded association of anger-out with BP progression (P trend = 0.02). The high anger-out values in models 1 and 2 were also significant after adjustment for multiple testing. The standardized regression analysis in model 2 confirmed this association; the risk of BP progression increased by 6% for each 1-SD increase in anger-out (PR 1.06; 95% CI ). The association attenuated after adjustment for risk factors in model 3. Participants with high depressive symptoms scores had a 14% increased risk of BP progression compared to those with low scores (PR 1.14; 95% CI ) after adjustment for age, sex, and SES. This association weakened after adjustment for risk factors. After adjustment for multiple testing, high depressive symptoms in model 2 was not significant; however, the continuous depressive symptoms value remained significant (P = 0.02). WSI-event analyses revealed that a greater number of minor stressors was associated with higher risk of BP progression in the 3 models (model 3, P trend = 0.04). WSI-impact was inversely associated with BP progression in each model, high (vs. low) MLE scores were associated with a 13% increased prevalence of BP progression, but estimates attenuated in the fully adjusted model. Participants with high cumulative stress scores had a 24% increased risk of 918 American Journal of Hypertension 29(8) August 2016

7 Psychosocial Factors and BP Progression Table 3. PRs of incident hypertension with psychosocial factors among African Americans, Jackson Heart Study, and Cases/people at risk Model 1 Model 2 Model 3 Cynical distrust Low (N = 351; 4.0 ± 1.6) 119/351 Referent Referent Referent Medium (N = 464; 7.0 ± 1.1) 166/ ( ) ( ) ( ) 0.19 High (N = 222; 11.0 ± 0.9) 80/ ( ) ( ) ( ) 0.52 P for trend Cynical distrust (SD units) 1.02 ( ) ( ) ( ) 0.37 Anger-in Low (N = 432; 3.0 ± 1.3) 155/432 Referent Referent Referent Medium (N = 248; 5.0 ± 0.5) 92/ ( ) ( ) ( ) 0.95 High (N = 377; 9.0 ± 2.8) 130/ ( ) ( ) ( ) 0.08 P for trend Anger-in (SD units) 0.99 ( ) ( ) ( ) 0.10 Anger-out Low (N = 435; 2.0 ± 1.0) 152/435 Referent Referent Referent Medium (N = 270; 5.0 ± 0.5) 85/ ( ) ( ) ( ) 0.11 High (N = 369; 8.0 ± 2.2) 145/ ( ) ( ) ( ) 0.71 P for trend Anger-out (SD units) 1.05 ( ) ( ) ( ) 0.94 Depressive symptoms Low (N = 375; 3.0 ± 2.0) 129/375 Referent Referent Referent Medium (N = 336; 9.0 ± 1.6) 112/ ( ) ( ) ( ) 0.53 High (N = 333; 17.0 ± 7.1) 132/ ( ) ( ) ( ) 0.74 P for trend Depression (SD units) 1.06 ( ) ( ) ( ) 0.52 WSI-event Low (N = 317; 12.0 ± 6.0) 106/317 Referent Referent Referent Medium (N = 413; 28.0 ± 5.1) 151/ ( ) ( ) ( ) 0.76 High (N = 452; 58.0 ± 15.8) 169/ ( ) ( ) ( ) 0.88 P for trend WSI-event (SD units) 1.00 ( ) ( ) ( ) 0.85 WSI-impact Low (N = 299; 20.0 ± 10.6) 99/299 Referent Referent Referent Medium (N = 335; 56.0 ± 14.5) 124/ ( ) ( ) ( ) 0.22 High (N = 381; ± 80.3) 131/ ( ) ( ) ( ) 0.64 P for trend WSI-impact (SD units) 0.98 ( ) ( ) ( ) 0.44 Major life events Low (N = 879; 2.0 ± 0.5) 294/879 Referent Referent Referent Medium (N = 360; 4.0 ± 0.0) 120/ ( ) ( ) ( ) 0.84 High (N = 271; 5.0 ± 1.0) 101/ ( ) ( ) ( ) 0.58 P for trend Major life events (SD units) 1.04 ( ) ( ) ( ) 0.57 American Journal of Hypertension 29(8) August

8 Ford et al. Table 3. Continued Cases/people at risk Model 1 Model 2 Model 3 Cumulative negative affect Low (N = 316; 5.0 ± 0.7) 107/316 Referent Referent Referent Medium (N = 390; 8.0 ± 0.8) 141/ ( ) ( ) ( ) 0.83 High (N = 215; 10.0 ± 0.7) 78/ ( ) ( ) ( ) 0.46 P for trend Cumulative negative affect 1.03 ( ) ( ) ( ) 0.65 (SD units) Cumulative stress Low (N = 268; 5.0 ± 0.8) 86/268 Referent Referent Referent Medium (N = 423; 8.0 ± 0.8) 134/ ( ) ( ) ( ) 0.78 High (N = 236; 10.0 ± 0.8) 86/ ( ) ( ) ( ) 0.73 P for trend Cumulative stress (SD units) 0.99 ( ) ( ) ( ) 0.88 Standardized regression coefficients for incident hypertension per 1-SD increment of each psychosocial factor. PR estimates for incident hypertension represent the risk of developing hypertension based on blood pressure and/or interview in examination 2 after being normotensive at baseline. Model 1 is adjusted for age, gender, and psychosocial factor; model 2 is adjusted for model 1 + education; model 3 is adjusted for model 2 + current smoking, sodium intake, calories from fat, total fiber, physical activity, BMI, type 2 diabetes, and total cholesterol. Cumulative negative affect is the combination of standardized cynical distrust, anger-in, anger-out, and depressive symptoms. Cumulative stress is the combination of standardized global perceived stress, WSI-event, WS-impact, and major life events stress. Abbreviations: BMI, body mass index; CI, confidence interval; PR, prevalence ratio; WSI, weekly stress inventory. BP progression than those with low scores (PR 1.24; 95% CI ) after full adjustment. Associations were graded, and standardized regression coefficients confirmed this association. Associations did not change when full models were adjusted for baseline SBP and DBP. Findings remained significant when considering adjusted s for multiple testing. There was no evidence of effect modification by sex in fully adjusted models, as indicated by the nonsignificant P values for interaction (data not shown). Select psychosocial factors were marginally associated with BP progression from normotensive status only to stage 1 and stage 2 hypertension (P < 0.1). In fully adjusted models, anger-out, depressive symptoms, WSI-event, and cumulative stress were positively associated with risk of BP progression from prehypertensive status to stage 1 and 2 hypertension (P < 0.05) (Supplementary Figure). Incident hypertension We did not observe a significant association with any of the psychosocial factors and incident hypertension (Table 3). There was attenuation in the PRs from models 1 to 3 for most measures, but no significant associations. Longitudinal changes While changes in SBP and DBP were examined, psychosocial factors were only associated with changes in DBP (Table 4). In the fully adjusted model, anger-out was associated with changes in DBP (mean difference in DBP: 2.73, P < 0.05). After full adjustment, high (vs. low) cumulative stress was associated with changes in DBP (mean difference in DBP: 3.67, P < 0.05). This association was graded from low to high cumulative stress (P for trend = 0.08) and was not significant according to the (0.02) for multiple testing. DISCUSSION This study investigated associations of psychosocial factors with BP end points among AA. To our knowledge, this is the first study to examine multiple psychosocial factors and BP end points in a large sample of AA. We found that high anger-out, depressive symptoms, WSI-event, MLE, and cumulative stress scores were associated with risk of BP progression. Associations of psychosocial factors with BP outcomes did not vary by sex. Psychosocial factors were not associated with incident hypertension. We did not observe a significant association of any of the psychosocial factors with incident hypertension. Anger-out and cumulative stress were significantly associated with changes in DBP. High WSI-event and cumulative stress scores significantly predicted the risk of BP progression, which suggests that the number and accumulation of stressors are important for understanding BP progression. One study found that anger was associated with progression from prehypertension to hypertension over a period of 3 6 years among AA. 41 Similarly, we found an association of anger-out with progression from prehypertension to hypertension after full 920 American Journal of Hypertension 29(8) August 2016

9 Psychosocial Factors and BP Progression Table 4. Mean differences in changes in SBP and DBP (SE) with psychosocial factors among African Americans, Jackson Heart Study, and (first imputation) Changes in SBP (SE) Changes in DBP (SE) Psychosocial measures Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Cynical distrust Low (n = 351) Referent Referent Referent Referent Referent Referent Medium (n = 464) 2.48 (2.02) 2.07 (2.04) 1.34 (2.14) 1.64 (1.25) 1.48 (1.27) 0.57 (1.32) High (n = 222) 0.41 (2.43) 0.21 (2.48) 1.07 (2.62) 1.92 (1.51) 1.78 (1.54) 1.27 (1.61) P for trend Cynical distrust (SD units) 0.79 (0.88) 0.57 (0.90) 0.18 (0.95) 0.65 (0.55) 0.57 (0.56) 0.32 (0.59) Anger-in Low (n = 432) Referent Referent Referent Referent Referent Referent Medium (n = 248) 1.33 (2.13) 1.39 (2.32) 1.59 (2.42) 1.19 (1.43) 1.13 (1.43) 1.06 (1.47) High (n = 377) 0.44 (2.04) 0.37 (2.04) 0.58 (2.13) 0.65 (1.26) 0.63 (1.26) 0.64 (1.29) P for trend Anger-in (SD units) 0.03 (0.88) 0.05 (0.88) 0.45 (0.91) 0.69 (0.54) 0.72 (0.54) 0.68 (0.55) Anger-out Low (n = 435) Referent Referent Referent Referent Referent Referent Medium (n = 270) 0.56 (2.24) 0.54 (2.24) 0.80 (2.33) 0.40 (1.36) 0.46 (1.36) 0.75 (1.40) High (n = 369) 0.79 (2.10) 0.87 (2.10) 0.91 (2.19) 2.22 (1.28) 2.30(1.28) 2.73 (1.31)*,a P for trend Anger-out (SD units) 0.53 (0.93) 0.53 (0.93) 0.71 (0.97) 0.81 (0.57) 0.82 (0.57) 0.84 (0.58) Depressive symptoms Low (n = 375) Referent Referent Referent Referent Referent Referent Medium (n = 336) 1.54 (2.15) 1.89 (2.18) 1.47 (2.26) 0.27 (1.33) 0.29 (1.35) 0.13 (1.38) High (n = 333) 0.40 (2.20) 0.00 (2.24) 0.17 (2.34) 1.21 (1.36) 1.18 (1.38) 1.27 (1.43) P for trend Depressive symptoms (SD units) 0.31 (0.96) 0.49 (0.97) 0.79 (1.01) 0.53 (0.59) 0.53 (0.60) 0.50 (0.62) Perceived stress Low (n = 469) Referent Referent Referent Referent Referent Referent Medium (n = 550) 1.95 (1.86) 1.83 (1.86) 1.55 (1.94) 1.29 (1.11) 1.32 (1.12) 1.11 (1.15) High (n = 628) 1.53 (1.83) 1.55 (1.83) 1.29 (1.94) 0.54 (1.10) 0.57 (1.10) 0.63 (1.15) P for trend Perceived stress (SD units) 0.77 (0.74) 0.80 (0.74) 0.93 (0.77) 0.24 (0.44) 0.25 (0.44) 0.36 (0.46) WSI-event Low (n = 317) Referent Referent Referent Referent Referent Referent Medium (n = 413) 0.35 (2.18) 0.57 (2.19) 1.08 (2.28) 2.33 (1.34) 2.38 (1.34) 2.63 (1.38) High (n = 452) 1.29 (2.20) 1.30 (2.20) 2.21 (2.31) 1.65 (1.35) 1.58 (1.35) 2.53 (1.40) P for trend WSI-event (SD units) 0.72 (0.87) 0.69 (0.87) 0.75 (0.91) 0.54 (0.53) 0.49 (0.54) 0.64 (0.55) WSI-impact Low (n = 299) Referent Referent Referent Referent Referent Referent Medium (n = 335) 0.67 (2.30) 0.74 (2.30) 1.38 (2.39) 0.77 (1.42) 0.68 (1.43) 1.46 (1.46) High (n = 381) 1.93 (2.28) 1.92 (2.29) 2.02 (2.38) 1.35 (1.41) 1.24 (1.41) 1.75 (1.45) P for trend WSI-impact (SD units) 1.13 (0.90) 1.12 (0.91) 1.19 (0.95) 0.88 (0.56) 0.86 (0.56) 1.04 (0.58) American Journal of Hypertension 29(8) August

10 Ford et al. Table 4. Continued Changes in SBP (SE) Changes in DBP (SE) Psychosocial measures Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Major life events Low (n = 879) Referent Referent Referent Referent Referent Referent Medium (n = 360) 0.54 (1.76) 0.63 (1.76) 0.72 (1.83) 1.71 (1.06) 1.70 (1.06) 1.40 (1.09) High (n = 271) 0.92 (1.98) 0.95 (1.98) 1.53 (2.04) 1.04 (1.19) 1.05 (1.19) 1.00 (1.22) P for trend Major life events (SD units) 0.40 (0.76) 0.40 (0.76) 0.56 (0.78) 0.41 (0.46) 0.40 (0.46) 0.42 (0.47) Cumulative negative affect Low (n = 316) Referent Referent Referent Referent Referent Referent Medium (n = 390) 2.27 (2.16) 2.13 (2.17) 2.61 (2.27) 1.50 (1.32) 1.46 (1.33) 1.93 (1.37) High (n = 215) 0.78 (2.54) 0.43 (2.56) 0.13 (2.69) 1.74 (1.55) 1.69 (1.57) 2.27 (1.63) P for trend Cumulative negative affect 0.19 (0.95) 0.05 (0.96) 0.07 (1.01) 0.69 (0.58) 0.67 (0.58) 0.92 (0.61) (SD units) Cumulative stress Low (n = 268) Referent Referent Referent Referent Referent Referent Medium (n = 423) 0.11 (2.19) 0.12 (2.19) 0.03 (2.30) 2.59 (1.36) 2.45 (1.36) 2.38 (1.41) High (n = 236) 2.94 (2.57) 2.95 (2.58) 2.96 (2.70) 3.52 (1.60)*,a 3.37 (1.60)*,a 3.67 (1.65)*,a P for trend Cumulative stress (SD units) 0.96 (0.98) 0.96 (0.98) 1.10 (1.03) 1.07 (0.61) 1.02 (0.61) 1.21 (0.63) PR represents prevalence ratio; low, medium, and high represent the first, second, and third tertile of each psychosocial factor at baseline. Model 1 is adjusted for age, gender, and psychosocial factor; model 2 is adjusted for model 1 + education; model 3 is adjusted for model 2 + current smoking, sodium intake, calories from fat, total fiber, physical activity, BMI, type 2 diabetes, and total cholesterol. P for trend represents the linear trend across categories for each psychosocial factor. First imputation for participants taking antihypertensive medications, Bs were imputed by adding 10 mm Hg to the SBP and 5 mm Hg to the DBP. Abbreviations: BMI, body mass index; BP, blood pressure; DBP, diastolic blood pressure; PR, prevalence ratio; SBP, systolic blood pressure; WSI, weekly stress inventory. a Bonferroni-adjusted for multiple testing: 0.02 (negative affect measures) and 0.02 (stress measures). P 0.1; *P adjustment, which suggests that the relationship is not fully explained by risk factors. We did not observe significant interactions by sex between psychosocial factors and BP end points, although research has found that anger and depression significantly predicted incident hypertension and changes in SBP among women. 20 Räikkönen et al. 20 also reported that an increase in psychological distress over time can affect individuals physiologically, which may be indicated in our pooled analysis. Previous research has also found that stress is associated with CVD risk primarily in men, 42 which was not found in our study. Previous studies have reported associations of psychosocial measures with incident hypertension One study of normotensive, middle-aged AA and White women (n = 541) found high levels of anger and anxiety were associated with hypertension risk. 20 Conversely, we did not observe any significant associations of any of the psychosocial factors with incident hypertension, which is consistent with one study that found no associations of depressive symptoms with incident hypertension among AA. 43 One potential reason we did not observe any significant associations may have been due to not accounting for time to diagnosis of events as previous studies have used. Our study also examined longitudinal changes in SBP and DBP, which has been examined by a few studies. One multiethnic study found associations of depressive symptoms and slight changes in SBP (+2.4 mm Hg) and DBP (+0.8 mm Hg) over a 2-year period. 43 We found associations of anger-out and cumulative stress and changes in DBP, which supports the association of stress on BP. One novel feature of our study included the examination of multiple psychosocial measures. Recent studies of psychosocial factors and BP have examined few negative affect measures. 41,43 We, however, examined 4 dimensions of negative affect and stress among AA. The examination of more than one dimension is important for representing the broad array of psychological ill-being which is important for predicting BP disparities. The cumulative exposure of these factors (vs. one at a time) may be a truer depiction of how multiple stressors predict chronic diseases among AA, a highly stressed population. Cumulative negative affect did not predict BP outcomes, which is similar to another study 922 American Journal of Hypertension 29(8) August 2016

11 Psychosocial Factors and BP Progression that found no associations between cumulative negativity and subclinical disease in a multiethnic sample. 16 The findings of this study should be evaluated in the context of several limitations. The study was conducted in a single metropolitan area in the Southeastern United States, possibly limiting its generalizability to other AA populations. The study sample was restricted to individuals that did not have hypertension at baseline. We recognize this may result in a survivor bias; however, the focus of the study was to identify normotensive individuals that developed hypertension over time by way of hypertension incidence and BP progression. We were unable to estimate incident hypertension using time to diagnosis. Participants that developed hypertension between examination 1 and 2 were likely placed on antihypertensive medications upon diagnosis. Although this was accounted for in our imputations that considered those taking antihypertensive medication, this may have affected our longitudinal analysis. The strengths of this study include utilizing JHS, the largest study of CVD in AA, to examine multiple dimensions of negative affect and stress and BP progression. The use of multiple BP end points is another strength. The use of BP progression longitudinally enabled us to draw causal inferences about psychosocial factors and BP progression unlike cross-sectional studies. In summary, psychosocial factors were associated with BP progression, with the strongest evidence for number of stressful events and accumulation of stressors that occurred, possibly contributing to the clustering of stressors among this AA population. Considering the high levels of stress and affective states reported by AA may be important for preventing the development of hypertension, and the extent to which coping strategies (e.g., family networks) might mitigate the association of psychosocial factors with BP end points among AA should be considered. Supplementary materials are available at American Journal of Hypertension ( ACKNOWLEDGMENTS We thank the Jackson Heart Study team (University of Mississippi Medical Center, Jackson State University, and Tougaloo College) and participants for their longterm commitment that continues to improve our understanding of the epidemiology of cardiovascular and other chronic diseases. The Jackson Heart Study is supported by contracts HHSN C, HHSN C, HHSN C, HHSN C, and HHSN C from the National Heart, Lung, and Blood Institute (NHLBI) and the National Institute on Minority Health and Health Disparities (NIMHD). Dr Sims is supported by the grants P60MD and U54MD from the NIMHD. C.D.F. and M.S. should be regarded as joint first authors. DISCLOSURE The authors declared no conflict of interest. REFERENCES 1. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, JAMA 2010; 303: Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Judd SE, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Mackey RH, Magid DJ, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER III, Moy CS, Mussolino ME, Neumar RW, Nichol G, Pandey DK, Paynter NP, Reeves MJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Wong ND, Woo D, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics 2014 update: a report from the American Heart Association. Circulation 2014; 129:e28 e Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Nichol G, Paynter NP, Schreiner PJ, Sorlie PD, Stein J, Turan TN, Virani SS, Wong ND, Woo D, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics 2013 update: a report from the American Heart Association. Circulation 2013; 127:e6 e Mujahid MS, Diez Roux AV, Cooper RC, Shea S, Williams DR. Neighborhood stressors and race/ethnic differences in hypertension prevalence (the Multi-Ethnic Study of Atherosclerosis). Am J Hypertens 2011; 24: Wong ND, Lopez VA, L Italien G, Chen R, Kline SE, Franklin SS. Inadequate control of hypertension in US adults with cardiovascular disease comorbidities in Arch Intern Med 2007; 167: Hertz RP, Unger AN, Cornell JA, Saunders E. Racial disparities in hypertension prevalence, awareness, and management. Arch Intern Med 2005; 165: Wyatt SB, Akylbekova EL, Wofford MR, Coady SA, Walker ER, Andrew ME, Keahey WJ, Taylor HA, Jones DW. Prevalence, awareness, treatment, and control of hypertension in the Jackson Heart Study. Hypertension 2008; 51: Dyer AR, Liu K, Walsh M, Kiefe C, Jacobs DR Jr, Bild DE. Ten-year incidence of elevated blood pressure and its predictors: the CARDIA study. Coronary Artery Risk Development in (Young) Adults. J Hum Hypertens 1999; 13: Hajjar I, Kotchen JM, Kotchen TA. Hypertension: trends in prevalence, incidence, and control. Annu Rev Public Health 2006; 27: Carson AP, Howard G, Burke GL, Shea S, Levitan EB, Muntner P. Ethnic differences in hypertension incidence among middle-aged and older adults: the multi-ethnic study of atherosclerosis. Hypertension 2011; 57: Lloyd-Jones DM, Evans JC, Levy D. Hypertension in adults across the age spectrum: current outcomes and control in the community. JAMA 2005; 294: Forman JP, Stampfer MJ, Curhan GC. Diet and lifestyle risk factors associated with incident hypertension in women. JAMA 2009; 302: Everson-Rose SA, Lewis TT. Psychosocial factors and cardiovascular diseases. Annu Rev Public Health 2005; 26: Sims M, Diez-Roux AV, Dudley A, Gebreab S, Wyatt SB, Bruce MA, James SA, Robinson JC, Williams DR, Taylor HA. Perceived discrimination and hypertension among African Americans in the Jackson Heart Study. Am J Public Health 2012; 102 Suppl 2:S258 S Ranjit N, Diez-Roux AV, Shea S, Cushman M, Seeman T, Jackson SA, Ni H. Psychosocial factors and inflammation in the multi-ethnic study of atherosclerosis. Arch Intern Med 2007; 167: Diez Roux AV, Ranjit N, Powell L, Jackson S, Lewis TT, Shea S, Wu C. Psychosocial factors and coronary calcium in adults without clinical cardiovascular disease. Ann Intern Med 2006; 144: Yan LL, Liu K, Matthews KA, Daviglus ML, Ferguson TF, Kiefe CI. Psychosocial factors and risk of hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) study. JAMA 2003; 290: American Journal of Hypertension 29(8) August

Effects of Paroxetine on Mortality and Hospital Admissions in Heart Failure Patients

Effects of Paroxetine on Mortality and Hospital Admissions in Heart Failure Patients Effects of Paroxetine on Mortality and Hospital Admissions in Heart Failure Patients MARIE ANN NGAN, PHARM.D. OKLAHOMA CITY VA HEALTH CARE SYSTEMS PGY1 PHARMACY RESIDENT APRIL 8, 2016 Disclosure Statement

More information

ORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults

ORIGINAL INVESTIGATION. C-Reactive Protein Concentration and Incident Hypertension in Young Adults ORIGINAL INVESTIGATION C-Reactive Protein Concentration and Incident Hypertension in Young Adults The CARDIA Study Susan G. Lakoski, MD, MS; David M. Herrington, MD, MHS; David M. Siscovick, MD, MPH; Stephen

More information

Diabetes Care Publish Ahead of Print, published online February 25, 2010

Diabetes Care Publish Ahead of Print, published online February 25, 2010 Diabetes Care Publish Ahead of Print, published online February 25, 2010 Undertreatment Of Mental Health Problems In Diabetes Undertreatment Of Mental Health Problems In Adults With Diagnosed Diabetes

More information

Heart Disease and Stroke Statistics 2018 At-a-Glance

Heart Disease and Stroke Statistics 2018 At-a-Glance Heart Disease and Stroke Statistics 2018 At-a-Glance Here are a few key statistics about heart disease, stroke, other cardiovascular diseases and their risk factors, in addition to commonly cited statistics

More information

A Needs Assessment of Hypertension in Georgia

A Needs Assessment of Hypertension in Georgia A Needs Assessment of Hypertension in Georgia Faye Lopez Mercer University School of Medicine Marylen Rimando Mercer University School of Medicine Harshali Khapekar Mercer University School of Medicine

More information

Risk Factors for Heart Disease

Risk Factors for Heart Disease Developmental Perspectives on Health Disparities from Conception Through Adulthood Risk Factors for Heart Disease Philip Greenland, MD Harry W. Dingman Professor Chair, Department of Preventive Medicine

More information

Cardiovascular diseases, including heart disease and

Cardiovascular diseases, including heart disease and Trends in Myocardial Infarction Secondary Prevention: The National Health and Nutrition Examination Surveys (NHANES), 1999 2012 Nilay S. Shah, MD, MPH; Mark D. Huffman, MD, MPH; Hongyan Ning, MD, MS; Donald

More information

Preview from Notesale.co.uk Page 4 of 42

Preview from Notesale.co.uk Page 4 of 42 ABSTRACT BACKGROUND This review aims to investigate the impact of ethnicity and culture on vascular problems such as hypertension and ischaemic stroke in Afro-Caribbean people who have Type 2 diabetes.

More information

Agenda CIAHD Monthly Research Meeting SPH I, Room 2610 November 14, :30 2:00pm est/11:30-12:00pm cst. I. CIAHD-Updates 10 minutes

Agenda CIAHD Monthly Research Meeting SPH I, Room 2610 November 14, :30 2:00pm est/11:30-12:00pm cst. I. CIAHD-Updates 10 minutes Agenda CIAHD Monthly Research Meeting SPH I, Room 2610 November 14, 2014 12:30 2:00pm est/11:30-12:00pm cst I. CIAHD-Updates 10 minutes II. Presentation: 45 minutes Samson Gebreab, PhD (NGHRI) Cross-sectional

More information

Society for Behavioral Medicine 33 rd Annual Meeting New Orleans, LA

Society for Behavioral Medicine 33 rd Annual Meeting New Orleans, LA Society for Behavioral Medicine 33 rd Annual Meeting New Orleans, LA John M. Violanti, PhD* a ; LuendaE. Charles, PhD, MPH b ; JaK. Gu, MSPH b ; Cecil M. Burchfiel, PhD, MPH b ; Michael E. Andrew, PhD

More information

YOUNG ADULT MEN AND MIDDLEaged

YOUNG ADULT MEN AND MIDDLEaged BRIEF REPORT Favorable Cardiovascular Profile in Young Women and Long-term of Cardiovascular and All-Cause Mortality Martha L. Daviglus, MD, PhD Jeremiah Stamler, MD Amber Pirzada, MD Lijing L. Yan, PhD,

More information

Physical Activity, Sedentary Behaviors and the Incidence of Type 2 Diabetes Mellitus: The Multi-

Physical Activity, Sedentary Behaviors and the Incidence of Type 2 Diabetes Mellitus: The Multi- Physical Activity, Sedentary Behaviors and the Incidence of Type 2 Diabetes Mellitus: The Multi- Ethnic Study of Atherosclerosis (MESA) Running Title: Physical Activity, Sedentary Behavior and Incident

More information

ARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority:

ARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority: ARIC Manuscript Proposal # 1475 PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority: 1.a. Full Title: Hypertension, left ventricular hypertrophy, and risk of incident hospitalized

More information

The Impact of Lifecourse Socioeconomic Position on Cardiovascular Disease Events in African Americans: The Jackson Heart Study

The Impact of Lifecourse Socioeconomic Position on Cardiovascular Disease Events in African Americans: The Jackson Heart Study The Impact of Lifecourse Socioeconomic Position on Cardiovascular Disease Events in African Americans: The Jackson Heart Study Samson Y. Gebreab, PhD, MSc; Ana V. Diez Roux, MD, PhD; Allison B. Brenner,

More information

Trends in Prevalence, Awareness, Management, and Control of Hypertension Among United States Adults, 1999 to 2010

Trends in Prevalence, Awareness, Management, and Control of Hypertension Among United States Adults, 1999 to 2010 Journal of the American College of Cardiology Vol. 60, No. 7, 2012 2012 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.04.026

More information

Using the New Hypertension Guidelines

Using the New Hypertension Guidelines Using the New Hypertension Guidelines Kamal Henderson, MD Department of Cardiology, Preventive Medicine, University of North Carolina School of Medicine Kotchen TA. Historical trends and milestones in

More information

ALLHAT. Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic

ALLHAT. Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic 1 U.S. Department of Health and Human Services National Institutes of Health Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker

More information

ORIGINAL INVESTIGATION. Effects of Prehypertension on Admissions and Deaths

ORIGINAL INVESTIGATION. Effects of Prehypertension on Admissions and Deaths ORIGINAL INVESTIGATION Effects of Prehypertension on Admissions and Deaths A Simulation Louise B. Russell, PhD; Elmira Valiyeva, PhD; Jeffrey L. Carson, MD Background: The Joint National Committee on Prevention,

More information

Alcohol consumption and blood pressure change: 5-year follow-up study of the association in normotensive workers

Alcohol consumption and blood pressure change: 5-year follow-up study of the association in normotensive workers (2001) 15, 367 372 2001 Nature Publishing Group All rights reserved 0950-9240/01 $15.00 www.nature.com/jhh ORIGINAL ARTICLE Alcohol consumption and blood pressure change: 5-year follow-up study of the

More information

Impact of Lifestyle Modification to Reduce Cardiovascular Disease Event Risk of High Risk Patients with Low Levels of HDL C

Impact of Lifestyle Modification to Reduce Cardiovascular Disease Event Risk of High Risk Patients with Low Levels of HDL C Impact of Lifestyle Modification to Reduce Cardiovascular Disease Event Risk of High Risk Patients with Low Levels of HDL C Thomas P. Bersot, M.D., Ph.D. Gladstone Institute of Cardiovascular Disease University

More information

Presenter Disclosure Information

Presenter Disclosure Information Reviewing the Latest Research and Chest Pain Guidelines and Hot Topics for 2015 Presenter Disclosure Information Kathleen Zell, RN, MSN Maureen Corl, MSN-DNP, APRN-CNP Reviewing the latest research and

More information

improving BP control and related outcomes. Ethn Dis. 2015;25[2]: Key Words: Hypertension, Blood Pressure, African American

improving BP control and related outcomes. Ethn Dis. 2015;25[2]: Key Words: Hypertension, Blood Pressure, African American APILOT STUDY EVALUATING A COMMUNITY-BASED INTERVENTION FOCUSED ON THE ISHIB IMPACT CARDIOVASCULAR RISK REDUCTION TOOLKIT IN AFRICAN AMERICAN PATIENTS WITH UNCONTROLLED HYPERTENSION Objective: To evaluate

More information

New Hypertension Guideline Recommendations for Adults July 7, :45-9:30am

New Hypertension Guideline Recommendations for Adults July 7, :45-9:30am Advances in Cardiovascular Disease 30 th Annual Convention and Reunion UERM-CMAA, Inc. Annual Convention and Scientific Meeting July 5-8, 2018 New Hypertension Guideline Recommendations for Adults July

More information

Hypertensive emergencies are defined by marked blood

Hypertensive emergencies are defined by marked blood Trends in the Incidence of Hypertensive Emergencies in US Emergency Departments From 2006 to 2013 Alexander T. Janke, BS; Candace D. McNaughton, MD, MPH, PhD; Aaron M. Brody, MD, MPH; Robert D. Welch,

More information

Long-term Blood Pressure Variability throughout Young Adulthood and Cognitive Function in Midlife; CARDIA study

Long-term Blood Pressure Variability throughout Young Adulthood and Cognitive Function in Midlife; CARDIA study The EPI/NPAM Spring 2014 Scientific Sessions, Hilton San Francisco Union Square, San Francisco, CA Northwestern Mar. 18-21, 2014 University Feinberg School of Medicine Long-term Blood Pressure Variability

More information

Prevalence of Hypertension in Semi-Urban area of Nepal

Prevalence of Hypertension in Semi-Urban area of Nepal ORIGINAL ARTICLE Prevalence of Hypertension in Semi-Urban area of Nepal Koju R*, Manandhar K*, Gurung R*, Pant P*, Bedi TRS* *Department of Internal Medicine, Dhulikhel Hospital KUH ABSTRACT Hypertension

More information

A n aly tical m e t h o d s

A n aly tical m e t h o d s a A n aly tical m e t h o d s If I didn t go to the screening at Farmers Market I would not have known about my kidney problems. I am grateful to the whole staff. They were very professional. Thank you.

More information

Jackson Heart Study Manuscript Proposal Form

Jackson Heart Study Manuscript Proposal Form Jackson Heart Study Manuscript Proposal Form Submission Date: 3/2/2016 Proposal ID: P0700 I. TITLE I. Title Information A. Proposal Title: Racial Discrimination and Mental Health in the Jackson Heart Study:

More information

Biostats Final Project Fall 2002 Dr. Chang Claire Pothier, Michael O'Connor, Carrie Longano, Jodi Zimmerman - CSU

Biostats Final Project Fall 2002 Dr. Chang Claire Pothier, Michael O'Connor, Carrie Longano, Jodi Zimmerman - CSU Biostats Final Project Fall 2002 Dr. Chang Claire Pothier, Michael O'Connor, Carrie Longano, Jodi Zimmerman - CSU Prevalence and Probability of Diabetes in Patients Referred for Stress Testing in Northeast

More information

Original Research PHARMACY PRACTICE

Original Research PHARMACY PRACTICE Lifestyle Medicine-Related Cardiovascular Risk Factor Changes in Employees Participating in a Pharmacist-Run Risk Reduction Program Thomas L. Lenz, PharmD; Nicole D. Gillespie, PharmD; Michele A. Faulkner,

More information

Director of the Israeli Institute for Quality in Medicine Israeli Medical Association July 1st, 2016

Director of the Israeli Institute for Quality in Medicine Israeli Medical Association July 1st, 2016 The differential effect of Atherosclerosis on end organ damage in adult and elderly patients with CVRF: New Algorithm for Hypertension Diagnosis and Treatment R. Zimlichman, FAHA, FASH, FESC, FESH Chief

More information

T. Suithichaiyakul Cardiomed Chula

T. Suithichaiyakul Cardiomed Chula T. Suithichaiyakul Cardiomed Chula The cardiovascular (CV) continuum: role of risk factors Endothelial Dysfunction Atherosclerosis and left ventricular hypertrophy Myocardial infarction & stroke Endothelial

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Kavousi M, Leening MJG, Nanchen D, et al. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines

More information

Review Article The role of systemic sclerosis on the coronary artery disease risk: a systematic review and meta-analysis

Review Article The role of systemic sclerosis on the coronary artery disease risk: a systematic review and meta-analysis Int J Clin Exp Med 2017;10(9):13009-13014 www.ijcem.com /ISSN:1940-5901/IJCEM0042007 Review Article The role of systemic sclerosis on the coronary artery disease risk: a systematic review and meta-analysis

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Li S, Chiuve SE, Flint A, et al. Better diet quality and decreased mortality among myocardial infarction survivors. JAMA Intern Med. Published online September 2, 2013. doi:10.1001/jamainternmed.2013.9768.

More information

Global Coronary Heart Disease Risk Assessment of U.S. Persons With the Metabolic. Syndrome. and Nathan D. Wong, PhD, MPH

Global Coronary Heart Disease Risk Assessment of U.S. Persons With the Metabolic. Syndrome. and Nathan D. Wong, PhD, MPH Diabetes Care Publish Ahead of Print, published online April 1, 2008 Global Coronary Heart Disease Risk Assessment of U.S. Persons With the Metabolic Syndrome Khiet C. Hoang MD, Heli Ghandehari, BS, Victor

More information

Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women

Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women European Heart Journal (2002) 23, 528 535 doi:10.1053/euhj.2001.2888, available online at http://www.idealibrary.com on Combined effects of systolic blood pressure and serum cholesterol on cardiovascular

More information

NIH Public Access Author Manuscript JAMA Intern Med. Author manuscript; available in PMC 2015 August 01.

NIH Public Access Author Manuscript JAMA Intern Med. Author manuscript; available in PMC 2015 August 01. NIH Public Access Author Manuscript Published in final edited form as: JAMA Intern Med. 2014 August ; 174(8): 1397 1400. doi:10.1001/jamainternmed.2014.2492. Prevalence and Characteristics of Systolic

More information

2/11/2019 CLINICAL IMPLEMENTATION OF THE UPDATED BP GUIDELINES DUALITY OF INTEREST

2/11/2019 CLINICAL IMPLEMENTATION OF THE UPDATED BP GUIDELINES DUALITY OF INTEREST CLINICAL IMPLEMENTATION OF THE UPDATED BP GUIDELINES George L. Bakris, M.D.,F.A.S.N., F.A.H.A. Professor of Medicine Director, Am Heart Assoc. Comprehensive Hypertension Center University of Chicago Medicine

More information

HYPERTENSION: ARE WE GOING TOO LOW?

HYPERTENSION: ARE WE GOING TOO LOW? HYPERTENSION: ARE WE GOING TOO LOW? George L. Bakris, M.D.,F.A.S.N.,F.A.S.H., F.A.H.A. Professor of Medicine Director, ASH Comprehensive Hypertension Center University of Chicago Medicine Chicago, IL USA

More information

Dietary Fatty Acids and the Risk of Hypertension in Middle-Aged and Older Women

Dietary Fatty Acids and the Risk of Hypertension in Middle-Aged and Older Women 07/14/2010 Dietary Fatty Acids and the Risk of Hypertension in Middle-Aged and Older Women First Author: Wang Short Title: Dietary Fatty Acids and Hypertension Risk in Women Lu Wang, MD, PhD, 1 JoAnn E.

More information

Hypertension awareness, treatment, and control

Hypertension awareness, treatment, and control O r i g i n a l P a p e r Prevalence of Self-Reported High Blood Pressure Awareness, Advice Received From Health Professionals, and Actions Taken to Reduce High Blood Pressure Among US Adults Healthstyles

More information

Intermediate Methods in Epidemiology Exercise No. 4 - Passive smoking and atherosclerosis

Intermediate Methods in Epidemiology Exercise No. 4 - Passive smoking and atherosclerosis Intermediate Methods in Epidemiology 2008 Exercise No. 4 - Passive smoking and atherosclerosis The purpose of this exercise is to allow students to recapitulate issues discussed throughout the course which

More information

Combination Therapy for Hypertension

Combination Therapy for Hypertension Combination Therapy for Hypertension Se-Joong Rim, MD Cardiology Division, Yonsei University College of Medicine, Seoul, Korea Goals of Therapy Reduce CVD and renal morbidity and mortality. Treat to BP

More information

Risk Factors for Heart Disease

Risk Factors for Heart Disease Risk Factors for Heart Disease Risk Factors we cannot change (Age, Gender, Family History) Risk Factors we can change (modifiable) Smoking Blood pressure Cholesterol Diabetes Inactivity Overweight Stress

More information

Original Research Article

Original Research Article A STUDY TO ESTIMATE SUBCLINICAL ATHEROSCLEROSIS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS BY MEASURING THE CAROTID INTIMAL MEDIAL THICKNESS Natarajan Kandasamy 1, Rajan Ganesan 2, Thilakavathi Rajendiran

More information

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY VOL. 64, NO. 10, 2014 ª 2014 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN /$36.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY VOL. 64, NO. 10, 2014 ª 2014 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN /$36. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY VOL. 64, NO. 1, 214 ª 214 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 735-197/$36. PUBLISHED BY ELSEVIER INC. http://dx.doi.org/1.116/j.jacc.214.6.1186

More information

Hypertension Guidelines 2017

Hypertension Guidelines 2017 Hypertension Guidelines 2017 (American College of Cardiology and the American Heart Association) In 1977, the 1st comprehensive guideline for detection, evaluation, and management of high BP was published,

More information

Cardiovascular Disease Risk Factors and Blood Pressure Control in Ambulatory Care Visits to Physician Offices in the U.S.

Cardiovascular Disease Risk Factors and Blood Pressure Control in Ambulatory Care Visits to Physician Offices in the U.S. Cardiovascular Disease Risk Factors and Blood Pressure Control in Ambulatory Care Visits to Physician Offices in the U.S. Item Type Thesis Authors Couch, Christopher Rights Copyright is held by the author.

More information

High-Normal Blood Pressure Progression to Hypertension in the Framingham Heart Study

High-Normal Blood Pressure Progression to Hypertension in the Framingham Heart Study 22 High- Blood Pressure Progression to Hypertension in the Framingham Heart Study Mark Leitschuh, L. Adrienne Cupples, William Kannel, David Gagnon, and Aram Chobanian This study sought to determine if

More information

Hypertension Diagnosis and Physician Consult to Reduce Salt Intake

Hypertension Diagnosis and Physician Consult to Reduce Salt Intake Hypertension Diagnosis and Physician Consult to Reduce Salt Intake Reuben William Horace II* Brown University School of Public Health, Providence, Rhode Island Research Article Received date: 10/05/2017

More information

EXAMINING THE EDUCATION GRADIENT IN CHRONIC ILLNESS

EXAMINING THE EDUCATION GRADIENT IN CHRONIC ILLNESS EXAMINING THE EDUCATION GRADIENT IN CHRONIC ILLNESS PINKA CHATTERJI, HEESOO JOO, AND KAJAL LAHIRI Department of Economics, University at Albany: SUNY February 6, 2012 This research was supported by the

More information

Clinical Recommendations: Patients with Periodontitis

Clinical Recommendations: Patients with Periodontitis The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: Periodontitis and Atherosclerotic Cardiovascular Disease. Friedewald VE, Kornman KS, Beck JD, et al. J Periodontol 2009;

More information

Statistical Fact Sheet Populations

Statistical Fact Sheet Populations Statistical Fact Sheet Populations At-a-Glance Summary Tables Men and Cardiovascular Diseases Mexican- American Males Diseases and Risk Factors Total Population Total Males White Males Black Males Total

More information

Todd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM

Todd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM Todd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM Faculty Disclosure I have no financial interest to disclose No off-label use of medications will be discussed FIFTH ANNUAL SYMPOSIUM Recognize changes between

More information

Sudden cardiac death (SCD) is a leading cause of death in

Sudden cardiac death (SCD) is a leading cause of death in Lifetime Risk for Sudden Cardiac Death in the Community Brittany M. Bogle, PhD, MPH; Hongyan Ning, MD, MS; Sanjay Mehrotra, PhD; Jeffrey J. Goldberger, MD; Donald M. Lloyd-Jones, MD, ScM Background- Sudden

More information

The relation between arterial blood pressure (BP) and

The relation between arterial blood pressure (BP) and Ten-Year Blood Pressure Trajectories, Cardiovascular Mortality, and Life Years Lost in 2 Extinction Cohorts: the Minnesota Business and Professional Men Study and the Zutphen Study Susanne M. A. J. Tielemans,

More information

Blood pressure (BP) is an established major risk factor for

Blood pressure (BP) is an established major risk factor for Pulse Pressure Compared With Other Blood Pressure Indexes in the Prediction of 25-Year Cardiovascular and All-Cause Mortality Rates The Chicago Heart Association Detection Project in Industry Study Katsuyuki

More information

Comparison And Application Of Methods To Address Confounding By Indication In Non- Randomized Clinical Studies

Comparison And Application Of Methods To Address Confounding By Indication In Non- Randomized Clinical Studies University of Massachusetts Amherst ScholarWorks@UMass Amherst Masters Theses 1911 - February 2014 Dissertations and Theses 2013 Comparison And Application Of Methods To Address Confounding By Indication

More information

University of Padova, Padua, Italy, and HARVEST Study Group, Italy

University of Padova, Padua, Italy, and HARVEST Study Group, Italy University of Padova, Padua, Italy, and HARVEST Study Group, Italy ISOLATED SYSTOLIC HYPERTENSION IN THE YOUNG DOES NOT IMPLY AN INCREASED RISK OF FUTURE HYPERTENSION NEEDING TREATMENT Mos L, Saladini

More information

Egyptian Hypertension Guidelines

Egyptian Hypertension Guidelines Egyptian Hypertension Guidelines 2014 Egyptian Hypertension Guidelines Dalia R. ElRemissy, MD Lecturer of Cardiovascular Medicine Cairo University Why Egyptian Guidelines? Guidelines developed for rich

More information

Chronic kidney disease (CKD) has received

Chronic kidney disease (CKD) has received Participant Follow-up in the Kidney Early Evaluation Program (KEEP) After Initial Detection Allan J. Collins, MD, FACP, 1,2 Suying Li, PhD, 1 Shu-Cheng Chen, MS, 1 and Joseph A. Vassalotti, MD 3,4 Background:

More information

Atherosclerotic Disease Risk Score

Atherosclerotic Disease Risk Score Atherosclerotic Disease Risk Score Kavita Sharma, MD, FACC Diplomate, American Board of Clinical Lipidology Director of Prevention, Cardiac Rehabilitation and the Lipid Management Clinics September 16,

More information

CONSIDERABLE STRIDES HAVE

CONSIDERABLE STRIDES HAVE ORIGINAL INVESTIGATION Comparison of Risk Factors for Cardiovascular Mortality in Black and White Adults Mercedes R. Carnethon, PhD; Elizabeth B. Lynch, PhD; Alan R. Dyer, PhD; Donald M. Lloyd-Jones, MD,

More information

Update in Hypertension

Update in Hypertension Update in Hypertension Eliseo J. PérezP rez-stable MD Professor of Medicine DGIM, Department of Medicine UCSF 20 May 2008 Declaration of full disclosure: No conflict of interest (I have never been funded

More information

Chapter 2 Epidemiology Awareness, Prevalence, and Control: Newest Findings on Hypertension in Blacks

Chapter 2 Epidemiology Awareness, Prevalence, and Control: Newest Findings on Hypertension in Blacks Chapter 2 Epidemiology Awareness, Prevalence, and Control: Newest Findings on Hypertension in Blacks Daniel T. Lackland and Brent M. Egan 2.1 Introduction The racial disparities in hypertension and hypertension-related

More information

A CROSS SECTIONAL STUDY OF RELATIONSHIP OF OBESITY INDICES WITH BLOOD PRESSURE AND BLOOD GLUCOSE LEVEL IN YOUNG ADULT MEDICAL STUDENTS

A CROSS SECTIONAL STUDY OF RELATIONSHIP OF OBESITY INDICES WITH BLOOD PRESSURE AND BLOOD GLUCOSE LEVEL IN YOUNG ADULT MEDICAL STUDENTS Original Article A CROSS SECTIONAL STUDY OF RELATIONSHIP OF OBESITY INDICES WITH BLOOD PRESSURE AND BLOOD GLUCOSE LEVEL IN YOUNG ADULT MEDICAL STUDENTS Renu Lohitashwa, Parwati Patil ABSTRACT Overweight

More information

Stroke A Journal of Cerebral Circulation

Stroke A Journal of Cerebral Circulation Stroke A Journal of Cerebral Circulation JULY-AUGUST VOL. 7 1976 NO. 4 Components of Blood Pressure and Risk of Atherothrombotic Brain Infarction: The Framingham Study WILLIAM B. KANNEL, M.D., THOMAS R.

More information

Analyzing diastolic and systolic blood pressure individually or jointly?

Analyzing diastolic and systolic blood pressure individually or jointly? Analyzing diastolic and systolic blood pressure individually or jointly? Chenglin Ye a, Gary Foster a, Lisa Dolovich b, Lehana Thabane a,c a. Department of Clinical Epidemiology and Biostatistics, McMaster

More information

Original Article Does ischemic burden on stress testing influence patient survival in subjects with known severe multi-vessel CAD?

Original Article Does ischemic burden on stress testing influence patient survival in subjects with known severe multi-vessel CAD? Am J Cardiovasc Dis 2017;7(2):48-52 www.ajcd.us /ISSN:2160-200X/AJCD0034539 Original Article Does ischemic burden on stress testing influence patient survival in subjects with known severe multi-vessel

More information

Supplemental Data. Genome-wide Association of Copy-Number Variation. Reveals an Association between Short Stature

Supplemental Data. Genome-wide Association of Copy-Number Variation. Reveals an Association between Short Stature The American Journal of Human Genetics, Volume 89 Supplemental Data Genome-wide Association of Copy-Number Variation Reveals an Association between Short Stature and the Presence of Low-Frequency Genomic

More information

Antihypertensive Trial Design ALLHAT

Antihypertensive Trial Design ALLHAT 1 U.S. Department of Health and Human Services Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic National Institutes

More information

MANAGEMENT OF HYPERTENSION: TREATMENT THRESHOLDS AND MEDICATION SELECTION

MANAGEMENT OF HYPERTENSION: TREATMENT THRESHOLDS AND MEDICATION SELECTION Management of Hypertension: Treatment Thresholds and Medication Selection Robert B. Baron, MD MS Professor and Associate Dean Declaration of full disclosure: No conflict of interest Presentation Goals

More information

Central pressures and prediction of cardiovascular events in erectile dysfunction patients

Central pressures and prediction of cardiovascular events in erectile dysfunction patients Central pressures and prediction of cardiovascular events in erectile dysfunction patients N. Ioakeimidis, K. Rokkas, A. Angelis, Z. Kratiras, M. Abdelrasoul, C. Georgakopoulos, D. Terentes-Printzios,

More information

Student Paper PRACTICE-BASED RESEARCH

Student Paper PRACTICE-BASED RESEARCH The Role of Clinical Pharmacists in Modifying Cardiovascular Disease Risk Factors Autumn Bagwell, PharmD. 1 ; Jessica W. Skelley, PharmD 2 ; Lana Saad, PharmD 3 ; Thomas Woolley, PhD 4 ; and DeeAnn Dugan,

More information

The Effects of Moderate Intensity Exercise on Lipoprotein-Lipid Profiles of Haramaya University Community

The Effects of Moderate Intensity Exercise on Lipoprotein-Lipid Profiles of Haramaya University Community International Journal of Scientific and Research Publications, Volume 4, Issue 4, April 214 1 The Effects of Moderate Intensity Exercise on Lipoprotein-Lipid Profiles of Haramaya University Community Mulugeta

More information

Diabetes Care 31: , 2008

Diabetes Care 31: , 2008 Cardiovascular and Metabolic Risk O R I G I N A L A R T I C L E Global Coronary Heart Disease Risk Assessment of Individuals With the Metabolic Syndrome in the U.S. KHIET C. HOANG, MD HELI GHANDEHARI VICTOR

More information

Blood Pressure LIMBO How Low To Go?

Blood Pressure LIMBO How Low To Go? Blood Pressure LIMBO How Low To Go? Joseph L. Kummer, MD, FACC Bryan Heart Spring Conference April 21 st, 2018 Hypertension Epidemiology Over a billion people have hypertension Major cause of morbidity

More information

Analytical Methods: the Kidney Early Evaluation Program (KEEP) The Kidney Early Evaluation program (KEEP) is a free, community based health

Analytical Methods: the Kidney Early Evaluation Program (KEEP) The Kidney Early Evaluation program (KEEP) is a free, community based health Analytical Methods: the Kidney Early Evaluation Program (KEEP) 2000 2006 Database Design and Study Participants The Kidney Early Evaluation program (KEEP) is a free, community based health screening program

More information

Update on Current Trends in Hypertension Management

Update on Current Trends in Hypertension Management Friday General Session Update on Current Trends in Hypertension Management Shawna Nesbitt, MD Associate Dean, Minority Student Affairs Associate Professor, Department of Internal Medicine Office of Student

More information

Chapter 3 - Does Low Well-being Modify the Effects of

Chapter 3 - Does Low Well-being Modify the Effects of Chapter 3 - Does Low Well-being Modify the Effects of PRISMA (Dutch DESMOND), a Structured Selfmanagement-education Program for People with Type 2 Diabetes? Published as: van Vugt M, de Wit M, Bader S,

More information

Awareness of Hypertension, Risk Factors and Complications among Attendants of a Primary Health Care Center In Jeddah, Saudi Arabia

Awareness of Hypertension, Risk Factors and Complications among Attendants of a Primary Health Care Center In Jeddah, Saudi Arabia IOSR Journal of Nursing and Health Science (IOSR-JNHS e-issn: 2320 1959.p- ISSN: 2320 1940 Volume 6, Issue 1 Ver. VIII (Jan. - Feb. 2017), PP 16-21 www.iosrjournals.org Awareness of Hypertension, Risk

More information

Preventing heart disease by controlling hypertension: Impact of hypertensive subtype, stage, age, and sex

Preventing heart disease by controlling hypertension: Impact of hypertensive subtype, stage, age, and sex Prevention and Rehabilitation Preventing heart disease by controlling hypertension: Impact of hypertensive subtype, stage, age, and sex Nathan D. Wong, PhD, a Gaurav Thakral, BS, a Stanley S. Franklin,

More information

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY VOL. 67, NO. 5, 2016 ª 2016 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN /$36.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY VOL. 67, NO. 5, 2016 ª 2016 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN /$36. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY VOL. 67, NO. 5, 2016 ª 2016 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 0735-1097/$36.00 PUBLISHED BY ELSEVIER http://dx.doi.org/10.1016/j.jacc.2015.10.037

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Pedersen SB, Langsted A, Nordestgaard BG. Nonfasting mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis. JAMA Intern Med. Published online November 7, 2016.

More information

AHA Statistical Update

AHA Statistical Update AHA Statistical Update Heart Disease and Stroke Statistics 2014 Update A Report From the American Heart Association WRITING GROUP MEMBERS Alan S. Go, MD; Dariush Mozaffarian, MD, DrPH, FAHA; Véronique

More information

Northwestern University Feinberg School of Medicine Calculating the CVD Risk Score: Which Tool for Which Patient?

Northwestern University Feinberg School of Medicine Calculating the CVD Risk Score: Which Tool for Which Patient? Northwestern University Feinberg School of Medicine Calculating the CVD Risk Score: Which Tool for Which Patient? Donald M. Lloyd-Jones, MD, ScM, FACC, FAHA Senior Associate Dean Chair, Department of Preventive

More information

Using Cardiovascular Risk to Guide Antihypertensive Treatment Implications For The Pre-elderly and Elderly

Using Cardiovascular Risk to Guide Antihypertensive Treatment Implications For The Pre-elderly and Elderly Using Cardiovascular Risk to Guide Antihypertensive Treatment Implications For The Pre-elderly and Elderly Paul Muntner, PhD MHS Professor and Vice Chair Department of Epidemiology University of Alabama

More information

Avoidant Coping Moderates the Association between Anxiety and Physical Functioning in Patients with Chronic Heart Failure

Avoidant Coping Moderates the Association between Anxiety and Physical Functioning in Patients with Chronic Heart Failure Avoidant Coping Moderates the Association between Anxiety and Physical Functioning in Patients with Chronic Heart Failure Eisenberg SA 1, Shen BJ 1, Singh K 1, Schwarz ER 2, Mallon SM 3 1 University of

More information

Elevated blood pressure (BP) is a major modifiable risk factor

Elevated blood pressure (BP) is a major modifiable risk factor Blood Pressure in Adulthood and Life Expectancy With Cardiovascular Disease in Men and Women Life Course Analysis Oscar H. Franco, Anna Peeters, Luc Bonneux, Chris de Laet Abstract Limited information

More information

4/4/17 HYPERTENSION TARGETS: WHAT DO WE DO NOW? SET THE STAGE BP IN CLINICAL TRIALS?

4/4/17 HYPERTENSION TARGETS: WHAT DO WE DO NOW? SET THE STAGE BP IN CLINICAL TRIALS? HYPERTENSION TARGETS: WHAT DO WE DO NOW? MICHAEL LEFEVRE, MD, MSPH PROFESSOR AND VICE CHAIR DEPARTMENT OF FAMILY AND COMMUNITY MEDICINE UNIVERSITY OF MISSOURI 4/4/17 DISCLOSURE: MEMBER OF THE JNC 8 PANEL

More information

ARIC STUDY MANUSCRIPT PROPOSAL # 714. PC Reviewed: 03/07/00 Status: Deferred Priority: SC Reviewed: Status: Priority:

ARIC STUDY MANUSCRIPT PROPOSAL # 714. PC Reviewed: 03/07/00 Status: Deferred Priority: SC Reviewed: Status: Priority: 1 ARIC STUDY MANUSCRIPT PROPOSAL # 714 PC Reviewed: 03/07/00 Status: Deferred Priority: SC Reviewed: Status: Priority: 1. a. Full Title: Effect of menopausal status on mood: The influence of demographic

More information

CHAPTER VI RESEARCH METHODOLOGY

CHAPTER VI RESEARCH METHODOLOGY CHAPTER VI RESEARCH METHODOLOGY 6.1 Research Design Research is an organized, systematic, data based, critical, objective, scientific inquiry or investigation into a specific problem, undertaken with the

More information

Slide notes: References:

Slide notes: References: 1 2 3 Cut-off values for the definition of hypertension are systolic blood pressure (SBP) 135 and/or diastolic blood pressure (DBP) 85 mmhg for home blood pressure monitoring (HBPM) and daytime ambulatory

More information

Hypertension. Risk of cardiovascular disease beginning at 115/75 mmhg doubles with every 20/10mm Hg increase. (Grade B)

Hypertension. Risk of cardiovascular disease beginning at 115/75 mmhg doubles with every 20/10mm Hg increase. (Grade B) Practice Guidelines and Principles: Guidelines and principles are intended to be flexible. They serve as reference points or recommendations, not rigid criteria. Guidelines and principles should be followed

More information

Positive Psychosocial Factors & Antiretroviral Adherence among HIV-infected African Americans

Positive Psychosocial Factors & Antiretroviral Adherence among HIV-infected African Americans Positive Psychosocial Factors & Antiretroviral Adherence among HIV-infected African Americans Shenell D. Evans, PhD HIV Center For Clinical And Behavioral Studies New York State Psychiatric Institute And

More information

Diabetes Mellitus: A Cardiovascular Disease

Diabetes Mellitus: A Cardiovascular Disease Diabetes Mellitus: A Cardiovascular Disease Nestoras Mathioudakis, M.D. Assistant Professor of Medicine Division of Endocrinology, Diabetes, & Metabolism September 30, 2013 1 The ABCs of cardiovascular

More information

Hypertension Management in Minorities: Closing the gap

Hypertension Management in Minorities: Closing the gap Hypertension Management in Minorities: Closing the gap Gbemiga Sofowora, MBChB, Msc, FACC Summary Epidemiology Hypertension Target organ damage Death Pathophysiology Factors linked to poor BP control in

More information

Risk Assessment of developing type 2 diabetes mellitus in patient on antihypertensive medication

Risk Assessment of developing type 2 diabetes mellitus in patient on antihypertensive medication 41 Research Article Risk Assessment of developing type 2 diabetes mellitus in patient on antihypertensive medication Amarjeet Singh*, Sudeep bhardwaj, Ashutosh aggarwal Department of Pharmacology, Seth

More information